Together this demonstrates that although a large proportion of the patients in this SLE cohort have a decreased ability to degrade chromatin from particular cellular sources, when analyzed on pure and denatured DNA the activity of the serum DNase-I complex is not significantly decreased compared to healthy controls. The gene discussed is DNASE1L3; the disease is systemic lupus erythematosus.